Price $69.86 |
Market Cap
8.08B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
18.3
|
P/B
2.29
|
P/S
0.65
|
Dividend %
-
|
|
P/CF
288.6
|
P/FCF
15.7
|
Op. Cash Flow
653K
|
FCF
3.9
|
|
Op. Margin
5.20%
|
Net Margin
3.60%
|
ROE
13.00%
|
ROI
12.60%
|
|
ROA
5.30%
|
EPS Growth
-26.80%
|
Current Ratio
1.8
|
Debt/Equity
30.20%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Myomo Inc (MYO) | $3.77 | - | - | 35.8M | Strong Buy |
| InMed Pharmaceuticals Inc (INM) | $0.27 | - | - | 1.6M | Strong Buy |
| iCAD Inc (ICAD) | $1.51 | - | - | 38.2M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.73 | - | - | 183.6M | Strong Buy |
| Generation Bio Co (GBIO) | $2.32 | - | - | 65.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
